Endocrine Adverse Events of Nivolumab in Non-Small Cell Lung Cancer Patients—Literature Review

In recent years, we have observed significant progress in cancer treatment associated with the development of immunotherapy. A programmed cell death 1 molecule (PD-1) on the surface of T lymphocytes may be stimulated via a specific PD-ligand 1 (PD-L1), which inhibits lymphocyte activation and leads...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudzińska, Marta, Szczyrek, Michał, Wojas-Krawczyk, Kamila, Świrska, Joanna, Chmielewska, Izabela, Zwolak, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466155/
https://www.ncbi.nlm.nih.gov/pubmed/32824462
http://dx.doi.org/10.3390/cancers12082314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466155/
https://www.ncbi.nlm.nih.gov/pubmed/32824462
http://dx.doi.org/10.3390/cancers12082314

Ejemplares similares